aluates Reports

$ 0.0

Automative

Global Cardiopulmonary Autotransfusion System Market Research Report 2026

Published Date: 2026-02-04

Report Code: QYRE-Auto-10R2695

Global Cardiopulmonary Autotransfusion System Market Insights Forecast to 2026

BUY CHAPTERS

Global Cardiopulmonary Autotransfusion System Market Research Report 2026

Code: QYRE-Auto-10R2695

Report

2026-02-04

Pages:110

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Haemonetics

Medtronic Inc

LivaNova

Fresenius Kabi

Terumo

Wandong Health Sources

Cardiopulmonary Autotransfusion System Market Size

The global Cardiopulmonary Autotransfusion System market was valued at US$ 592 million in 2025 and is anticipated to reach US$ 697 million by 2032, at a CAGR of 2.4% from 2026 to 2032.

Cardiopulmonary Autotransfusion System Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Cardiopulmonary Autotransfusion System competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Cardiopulmonary Autotransfusion System is a sophisticated device with an exceptionally effective design that provides autologous blood during surgical procedures.

Autotransfusion is a process wherein a person receives their own blood for a transfusion, instead of banked allogenic (separate-donor) blood. There are two main kinds of Autotransfusion: Blood can be autologous "pre-donated" (termed so despite "donation" not typically referring to giving to one"s self) before a surgery, or alternatively, it can be collected during and after the surgery using an intraoperative blood salvage device. The latter form of Autotransfusion is utilized in surgeries where there is expected a large volume blood loss.

The major players in global Cardiopulmonary Autotransfusion System market include Haemonetics, Medtronic, LivaNova, etc. The top 3 players occupy about 70% shares of the global market. North America and Europe are main markets, they occupy about 80% of the global market. Washed ATS is the main type, with a share about 90%. Heart Surgery is the main application, which holds a share about 35%.

This report delivers a comprehensive overview of the global Cardiopulmonary Autotransfusion System market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Cardiopulmonary Autotransfusion System. The Cardiopulmonary Autotransfusion System market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Cardiopulmonary Autotransfusion System market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Cardiopulmonary Autotransfusion System manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Cardiopulmonary Autotransfusion System Market Report

Report Metric	Details
Report Name	Cardiopulmonary Autotransfusion System Market
Accounted market size in 2025	US$ 592 million
Forecasted market size in 2032	US$ 697 million
CAGR	2.4%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Unwashed ATS Washed ATS
by Application	Heart Surgery Great Organ Transplant Surgery Other Surgery
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Haemonetics, Medtronic, LivaNova, Fresenius Kabi, Terumo, Wandong Health Sources
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Cardiopulmonary Autotransfusion System manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Cardiopulmonary Autotransfusion System sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Cardiopulmonary Autotransfusion System Market growing?

Ans: The Cardiopulmonary Autotransfusion System Market witnessing a CAGR of 2.4% during the forecast period 2026-2032.

What is the Cardiopulmonary Autotransfusion System Market size in 2032?

Ans: The Cardiopulmonary Autotransfusion System Market size in 2032 will be US$ 697 million.

What is the market share of major companies in Cardiopulmonary Autotransfusion System Market?

Ans: The top 3 players occupy about 70% shares of the global market.

What is the Cardiopulmonary Autotransfusion System Market share by type?

Ans: Washed ATS is the main type, with a share about 90%.

What is the Cardiopulmonary Autotransfusion System Market share by application?

Ans: Heart Surgery is the main application, which holds a share about 35%.

Who are the main players in the Cardiopulmonary Autotransfusion System Market report?

Ans: The main players in the Cardiopulmonary Autotransfusion System Market are Haemonetics, Medtronic, LivaNova, Fresenius Kabi, Terumo, Wandong Health Sources

What are the Application segmentation covered in the Cardiopulmonary Autotransfusion System Market report?

Ans: The Applications covered in the Cardiopulmonary Autotransfusion System Market report are Heart Surgery, Great Organ Transplant Surgery, Other Surgery

What are the Type segmentation covered in the Cardiopulmonary Autotransfusion System Market report?

Ans: The Types covered in the Cardiopulmonary Autotransfusion System Market report are Unwashed ATS, Washed ATS

1 Cardiopulmonary Autotransfusion System Market Overview

1.1 Product Definition

1.2 Cardiopulmonary Autotransfusion System by Type

1.2.1 Global Cardiopulmonary Autotransfusion System Market Value by Type: 2025 vs 2032

1.2.2 Unwashed ATS

1.2.3 Washed ATS

1.3 Cardiopulmonary Autotransfusion System by Application

1.3.1 Global Cardiopulmonary Autotransfusion System Market Value by Application: 2025 vs 2032

1.3.2 Heart Surgery

1.3.3 Great Organ Transplant Surgery

1.3.4 Other Surgery

1.4 Global Cardiopulmonary Autotransfusion System Market Size Estimates and Forecasts

1.4.1 Global Cardiopulmonary Autotransfusion System Revenue 2021–2032

1.4.2 Global Cardiopulmonary Autotransfusion System Sales 2021–2032

1.4.3 Global Cardiopulmonary Autotransfusion System Market Average Price (2021–2032)

1.5 Assumptions and Limitations

2 Cardiopulmonary Autotransfusion System Market Competition by Manufacturers

2.1 Global Cardiopulmonary Autotransfusion System Sales Market Share by Manufacturers (2021–2026)

2.2 Global Cardiopulmonary Autotransfusion System Revenue Market Share by Manufacturers (2021–2026)

2.3 Global Cardiopulmonary Autotransfusion System Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of Cardiopulmonary Autotransfusion System, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of Cardiopulmonary Autotransfusion System, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of Cardiopulmonary Autotransfusion System, Product Types and Applications

2.7 Global Key Manufacturers of Cardiopulmonary Autotransfusion System, Date of Entry into the Industry

2.8 Global Cardiopulmonary Autotransfusion System Market Competitive Situation and Trends

2.8.1 Global Cardiopulmonary Autotransfusion System Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global Cardiopulmonary Autotransfusion System Players Market Share by Revenue

2.8.3 Global Cardiopulmonary Autotransfusion System Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Cardiopulmonary Autotransfusion System Market Scenario by Region

3.1 Global Cardiopulmonary Autotransfusion System Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global Cardiopulmonary Autotransfusion System Sales by Region: 2021–2032

3.2.1 Global Cardiopulmonary Autotransfusion System Sales by Region: 2021–2026

3.2.2 Global Cardiopulmonary Autotransfusion System Sales by Region: 2027–2032

3.3 Global Cardiopulmonary Autotransfusion System Revenue by Region: 2021–2032

3.3.1 Global Cardiopulmonary Autotransfusion System Revenue by Region: 2021–2026

3.3.2 Global Cardiopulmonary Autotransfusion System Revenue by Region: 2027–2032

3.4 North America Cardiopulmonary Autotransfusion System Market Facts & Figures by Country

3.4.1 North America Cardiopulmonary Autotransfusion System Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America Cardiopulmonary Autotransfusion System Sales by Country (2021–2032)

3.4.3 North America Cardiopulmonary Autotransfusion System Revenue by Country (2021–2032)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Cardiopulmonary Autotransfusion System Market Facts & Figures by Country

3.5.1 Europe Cardiopulmonary Autotransfusion System Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe Cardiopulmonary Autotransfusion System Sales by Country (2021–2032)

3.5.3 Europe Cardiopulmonary Autotransfusion System Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Cardiopulmonary Autotransfusion System Market Facts & Figures by Region

3.6.1 Asia Pacific Cardiopulmonary Autotransfusion System Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific Cardiopulmonary Autotransfusion System Sales by Region (2021–2032)

3.6.3 Asia Pacific Cardiopulmonary Autotransfusion System Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Cardiopulmonary Autotransfusion System Market Facts & Figures by Country

3.7.1 Latin America Cardiopulmonary Autotransfusion System Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America Cardiopulmonary Autotransfusion System Sales by Country (2021–2032)

3.7.3 Latin America Cardiopulmonary Autotransfusion System Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Cardiopulmonary Autotransfusion System Market Facts & Figures by Country

3.8.1 Middle East and Africa Cardiopulmonary Autotransfusion System Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa Cardiopulmonary Autotransfusion System Sales by Country (2021–2032)

3.8.3 Middle East and Africa Cardiopulmonary Autotransfusion System Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Cardiopulmonary Autotransfusion System Sales by Type (2021–2032)

4.1.1 Global Cardiopulmonary Autotransfusion System Sales by Type (2021–2026)

4.1.2 Global Cardiopulmonary Autotransfusion System Sales by Type (2027–2032)

4.1.3 Global Cardiopulmonary Autotransfusion System Sales Market Share by Type (2021–2032)

4.2 Global Cardiopulmonary Autotransfusion System Revenue by Type (2021–2032)

4.2.1 Global Cardiopulmonary Autotransfusion System Revenue by Type (2021–2026)

4.2.2 Global Cardiopulmonary Autotransfusion System Revenue by Type (2027–2032)

4.2.3 Global Cardiopulmonary Autotransfusion System Revenue Market Share by Type (2021–2032)

4.3 Global Cardiopulmonary Autotransfusion System Price by Type (2021–2032)

5 Segment by Application

5.1 Global Cardiopulmonary Autotransfusion System Sales by Application (2021–2032)

5.1.1 Global Cardiopulmonary Autotransfusion System Sales by Application (2021–2026)

5.1.2 Global Cardiopulmonary Autotransfusion System Sales by Application (2027–2032)

5.1.3 Global Cardiopulmonary Autotransfusion System Sales Market Share by Application (2021–2032)

5.2 Global Cardiopulmonary Autotransfusion System Revenue by Application (2021–2032)

5.2.1 Global Cardiopulmonary Autotransfusion System Revenue by Application (2021–2026)

5.2.2 Global Cardiopulmonary Autotransfusion System Revenue by Application (2027–2032)

5.2.3 Global Cardiopulmonary Autotransfusion System Revenue Market Share by Application (2021–2032)

5.3 Global Cardiopulmonary Autotransfusion System Price by Application (2021–2032)

6 Key Companies Profiled

6.1 Haemonetics

6.1.1 Haemonetics Company Information

6.1.2 Haemonetics Description and Business Overview

6.1.3 Haemonetics Cardiopulmonary Autotransfusion System Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 Haemonetics Cardiopulmonary Autotransfusion System Product Portfolio

6.1.5 Haemonetics Recent Developments/Updates

6.2 Medtronic

6.2.1 Medtronic Company Information

6.2.2 Medtronic Description and Business Overview

6.2.3 Medtronic Cardiopulmonary Autotransfusion System Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 Medtronic Cardiopulmonary Autotransfusion System Product Portfolio

6.2.5 Medtronic Recent Developments/Updates

6.3 LivaNova

6.3.1 LivaNova Company Information

6.3.2 LivaNova Description and Business Overview

6.3.3 LivaNova Cardiopulmonary Autotransfusion System Sales, Revenue, and Gross Margin (2021–2026)

6.3.4 LivaNova Cardiopulmonary Autotransfusion System Product Portfolio

6.3.5 LivaNova Recent Developments/Updates

6.4 Fresenius Kabi

6.4.1 Fresenius Kabi Company Information

6.4.2 Fresenius Kabi Description and Business Overview

6.4.3 Fresenius Kabi Cardiopulmonary Autotransfusion System Sales, Revenue, and Gross Margin (2021–2026)

6.4.4 Fresenius Kabi Cardiopulmonary Autotransfusion System Product Portfolio

6.4.5 Fresenius Kabi Recent Developments/Updates

6.5 Terumo

6.5.1 Terumo Company Information

6.5.2 Terumo Description and Business Overview

6.5.3 Terumo Cardiopulmonary Autotransfusion System Sales, Revenue, and Gross Margin (2021–2026)

6.5.4 Terumo Cardiopulmonary Autotransfusion System Product Portfolio

6.5.5 Terumo Recent Developments/Updates

6.6 Wandong Health Sources

6.6.1 Wandong Health Sources Company Information

6.6.2 Wandong Health Sources Description and Business Overview

6.6.3 Wandong Health Sources Cardiopulmonary Autotransfusion System Sales, Revenue, and Gross Margin (2021–2026)

6.6.4 Wandong Health Sources Cardiopulmonary Autotransfusion System Product Portfolio

6.6.5 Wandong Health Sources Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Cardiopulmonary Autotransfusion System Industry Chain Analysis

7.2 Cardiopulmonary Autotransfusion System Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Cardiopulmonary Autotransfusion System Production Mode & Process Analysis

7.4 Cardiopulmonary Autotransfusion System Sales and Marketing

7.4.1 Cardiopulmonary Autotransfusion System Sales Channels

7.4.2 Cardiopulmonary Autotransfusion System Distributors

7.5 Cardiopulmonary Autotransfusion System Customer Analysis

8 Cardiopulmonary Autotransfusion System Market Dynamics

8.1 Cardiopulmonary Autotransfusion System Industry Trends

8.2 Cardiopulmonary Autotransfusion System Market Drivers

8.3 Cardiopulmonary Autotransfusion System Market Challenges

8.4 Cardiopulmonary Autotransfusion System Market Restraints

8.5 Impact of U.S. Tariffs

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Haemonetics

Medtronic Inc

LivaNova

Fresenius Kabi

Terumo

Wandong Health Sources

List of Tables

Table 1. Global Cardiopulmonary Autotransfusion System Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global Cardiopulmonary Autotransfusion System Market Value by Application (US$ Million), 2025 vs 2032

Table 3. Global Cardiopulmonary Autotransfusion System Market Competitive Situation by Manufacturers in 2025

Table 4. Global Cardiopulmonary Autotransfusion System Sales (K Units) of Key Manufacturers (2021–2026)

Table 5. Global Cardiopulmonary Autotransfusion System Sales Market Share by Manufacturers (2021–2026)

Table 6. Global Cardiopulmonary Autotransfusion System Revenue (US$ Million) by Manufacturers (2021–2026)

Table 7. Global Cardiopulmonary Autotransfusion System Revenue Share by Manufacturers (2021–2026)

Table 8. Global Market Cardiopulmonary Autotransfusion System Average Price (USD/Unit) of Key Manufacturers (2021–2026)

Table 9. Global Key Players of Cardiopulmonary Autotransfusion System, Industry Ranking, 2023 vs 2024 vs 2025

Table 10. Global Key Manufacturers of Cardiopulmonary Autotransfusion System, Manufacturing Sites and Headquarters

Table 11. Global Key Manufacturers of Cardiopulmonary Autotransfusion System, Product Types and Applications

Table 12. Global Key Manufacturers of Cardiopulmonary Autotransfusion System, Date of Entry into the Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Cardiopulmonary Autotransfusion System Companies by Tier (Tier 1, Tier 2, Tier 3), based on Cardiopulmonary Autotransfusion System Revenue, 2025

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Cardiopulmonary Autotransfusion System Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 17. Global Cardiopulmonary Autotransfusion System Sales by Region (K Units), 2021–2026

Table 18. Global Cardiopulmonary Autotransfusion System Sales Market Share by Region (2021–2026)

Table 19. Global Cardiopulmonary Autotransfusion System Sales by Region (K Units), 2027–2032

Table 20. Global Cardiopulmonary Autotransfusion System Sales Market Share by Region (2027–2032)

Table 21. Global Cardiopulmonary Autotransfusion System Revenue by Region (US$ Million), 2021–2026

Table 22. Global Cardiopulmonary Autotransfusion System Revenue Market Share by Region (2021–2026)

Table 23. Global Cardiopulmonary Autotransfusion System Revenue by Region (US$ Million), 2027–2032

Table 24. Global Cardiopulmonary Autotransfusion System Revenue Market Share by Region (2027–2032)

Table 25. North America Cardiopulmonary Autotransfusion System Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 26. North America Cardiopulmonary Autotransfusion System Sales by Country (K Units), 2021–2026

Table 27. North America Cardiopulmonary Autotransfusion System Sales by Country (K Units), 2027–2032

Table 28. North America Cardiopulmonary Autotransfusion System Revenue by Country (US$ Million), 2021–2026

Table 29. North America Cardiopulmonary Autotransfusion System Revenue by Country (US$ Million), 2027–2032

Table 30. Europe Cardiopulmonary Autotransfusion System Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 31. Europe Cardiopulmonary Autotransfusion System Sales by Country (K Units), 2021–2026

Table 32. Europe Cardiopulmonary Autotransfusion System Sales by Country (K Units), 2027–2032

Table 33. Europe Cardiopulmonary Autotransfusion System Revenue by Country (US$ Million), 2021–2026

Table 34. Europe Cardiopulmonary Autotransfusion System Revenue by Country (US$ Million), 2027–2032

Table 35. Asia Pacific Cardiopulmonary Autotransfusion System Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 36. Asia Pacific Cardiopulmonary Autotransfusion System Sales by Region (K Units), 2021–2026

Table 37. Asia Pacific Cardiopulmonary Autotransfusion System Sales by Region (K Units), 2027–2032

Table 38. Asia Pacific Cardiopulmonary Autotransfusion System Revenue by Region (US$ Million), 2021–2026

Table 39. Asia Pacific Cardiopulmonary Autotransfusion System Revenue by Region (US$ Million), 2027–2032

Table 40. Latin America Cardiopulmonary Autotransfusion System Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 41. Latin America Cardiopulmonary Autotransfusion System Sales by Country (K Units), 2021–2026

Table 42. Latin America Cardiopulmonary Autotransfusion System Sales by Country (K Units), 2027–2032

Table 43. Latin America Cardiopulmonary Autotransfusion System Revenue by Country (US$ Million), 2021–2026

Table 44. Latin America Cardiopulmonary Autotransfusion System Revenue by Country (US$ Million), 2027–2032

Table 45. Middle East and Africa Cardiopulmonary Autotransfusion System Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 46. Middle East and Africa Cardiopulmonary Autotransfusion System Sales by Country (K Units), 2021–2026

Table 47. Middle East and Africa Cardiopulmonary Autotransfusion System Sales by Country (K Units), 2027–2032

Table 48. Middle East and Africa Cardiopulmonary Autotransfusion System Revenue by Country (US$ Million), 2021–2026

Table 49. Middle East and Africa Cardiopulmonary Autotransfusion System Revenue by Country (US$ Million), 2027–2032

Table 50. Global Cardiopulmonary Autotransfusion System Sales (K Units) by Type (2021–2026)

Table 51. Global Cardiopulmonary Autotransfusion System Sales (K Units) by Type (2027–2032)

Table 52. Global Cardiopulmonary Autotransfusion System Sales Market Share by Type (2021–2026)

Table 53. Global Cardiopulmonary Autotransfusion System Sales Market Share by Type (2027–2032)

Table 54. Global Cardiopulmonary Autotransfusion System Revenue (US$ Million) by Type (2021–2026)

Table 55. Global Cardiopulmonary Autotransfusion System Revenue (US$ Million) by Type (2027–2032)

Table 56. Global Cardiopulmonary Autotransfusion System Revenue Market Share by Type (2021–2026)

Table 57. Global Cardiopulmonary Autotransfusion System Revenue Market Share by Type (2027–2032)

Table 58. Global Cardiopulmonary Autotransfusion System Price (USD/Unit) by Type (2021–2026)

Table 59. Global Cardiopulmonary Autotransfusion System Price (USD/Unit) by Type (2027–2032)

Table 60. Global Cardiopulmonary Autotransfusion System Sales (K Units) by Application (2021–2026)

Table 61. Global Cardiopulmonary Autotransfusion System Sales (K Units) by Application (2027–2032)

Table 62. Global Cardiopulmonary Autotransfusion System Sales Market Share by Application (2021–2026)

Table 63. Global Cardiopulmonary Autotransfusion System Sales Market Share by Application (2027–2032)

Table 64. Global Cardiopulmonary Autotransfusion System Revenue (US$ Million) by Application (2021–2026)

Table 65. Global Cardiopulmonary Autotransfusion System Revenue (US$ Million) by Application (2027–2032)

Table 66. Global Cardiopulmonary Autotransfusion System Revenue Market Share by Application (2021–2026)

Table 67. Global Cardiopulmonary Autotransfusion System Revenue Market Share by Application (2027–2032)

Table 68. Global Cardiopulmonary Autotransfusion System Price (USD/Unit) by Application (2021–2026)

Table 69. Global Cardiopulmonary Autotransfusion System Price (USD/Unit) by Application (2027–2032)

Table 70. Haemonetics Company Information

Table 71. Haemonetics Description and Business Overview

Table 72. Haemonetics Cardiopulmonary Autotransfusion System Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)

Table 73. Haemonetics Cardiopulmonary Autotransfusion System Product

Table 74. Haemonetics Recent Developments/Updates

Table 75. Medtronic Company Information

Table 76. Medtronic Description and Business Overview

Table 77. Medtronic Cardiopulmonary Autotransfusion System Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)

Table 78. Medtronic Cardiopulmonary Autotransfusion System Product

Table 79. Medtronic Recent Developments/Updates

Table 80. LivaNova Company Information

Table 81. LivaNova Description and Business Overview

Table 82. LivaNova Cardiopulmonary Autotransfusion System Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)

Table 83. LivaNova Cardiopulmonary Autotransfusion System Product

Table 84. LivaNova Recent Developments/Updates

Table 85. Fresenius Kabi Company Information

Table 86. Fresenius Kabi Description and Business Overview

Table 87. Fresenius Kabi Cardiopulmonary Autotransfusion System Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)

Table 88. Fresenius Kabi Cardiopulmonary Autotransfusion System Product

Table 89. Fresenius Kabi Recent Developments/Updates

Table 90. Terumo Company Information

Table 91. Terumo Description and Business Overview

Table 92. Terumo Cardiopulmonary Autotransfusion System Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)

Table 93. Terumo Cardiopulmonary Autotransfusion System Product

Table 94. Terumo Recent Developments/Updates

Table 95. Wandong Health Sources Company Information

Table 96. Wandong Health Sources Description and Business Overview

Table 97. Wandong Health Sources Cardiopulmonary Autotransfusion System Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)

Table 98. Wandong Health Sources Cardiopulmonary Autotransfusion System Product

Table 99. Wandong Health Sources Recent Developments/Updates

Table 100. Key Raw Materials Lists

Table 101. Raw Materials Key Suppliers Lists

Table 102. Cardiopulmonary Autotransfusion System Distributors List

Table 103. Cardiopulmonary Autotransfusion System Customers List

Table 104. Cardiopulmonary Autotransfusion System Market Trends

Table 105. Cardiopulmonary Autotransfusion System Market Drivers

Table 106. Cardiopulmonary Autotransfusion System Market Challenges

Table 107. Cardiopulmonary Autotransfusion System Market Restraints

Table 108. Research Programs/Design for This Report

Table 109. Key Data Information from Secondary Sources

Table 110. Key Data Information from Primary Sources

Table 111. Authors List of This Report

List of Figures

Figure 1. Product Picture of Cardiopulmonary Autotransfusion System

Figure 2. Global Cardiopulmonary Autotransfusion System Market Value by Type (US$ Million), 2021–2032

Figure 3. Global Cardiopulmonary Autotransfusion System Market Share by Type: 2025 & 2032

Figure 4. Unwashed ATS Product Picture

Figure 5. Washed ATS Product Picture

Figure 6. Global Cardiopulmonary Autotransfusion System Market Value by Application (US$ Million), 2021–2032

Figure 7. Global Cardiopulmonary Autotransfusion System Market Share by Application: 2025 & 2032

Figure 8. Heart Surgery

Figure 9. Great Organ Transplant Surgery

Figure 10. Other Surgery

Figure 11. Global Cardiopulmonary Autotransfusion System Revenue, (US$ Million), 2021 vs 2025 vs 2032

Figure 12. Global Cardiopulmonary Autotransfusion System Market Size (US$ Million), 2021–2032

Figure 13. Global Cardiopulmonary Autotransfusion System Sales (K Units), 2021–2032

Figure 14. Global Cardiopulmonary Autotransfusion System Average Price (USD/Unit), 2021–2032

Figure 15. Cardiopulmonary Autotransfusion System Report Years Considered

Figure 16. Cardiopulmonary Autotransfusion System Sales Share by Manufacturers in 2025

Figure 17. Global Cardiopulmonary Autotransfusion System Revenue Share by Manufacturers in 2025

Figure 18. Top 5 and Top 10 Global Cardiopulmonary Autotransfusion System Players: Market Share by Revenue in Cardiopulmonary Autotransfusion System in 2025

Figure 19. Cardiopulmonary Autotransfusion System Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 20. Global Cardiopulmonary Autotransfusion System Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Figure 21. North America Cardiopulmonary Autotransfusion System Sales Market Share by Country (2021–2032)

Figure 22. North America Cardiopulmonary Autotransfusion System Revenue Market Share by Country (2021–2032)

Figure 23. U.S. Cardiopulmonary Autotransfusion System Revenue Growth Rate (US$ Million), 2021–2032

Figure 24. Canada Cardiopulmonary Autotransfusion System Revenue Growth Rate (US$ Million), 2021–2032

Figure 25. Europe Cardiopulmonary Autotransfusion System Sales Market Share by Country (2021–2032)

Figure 26. Europe Cardiopulmonary Autotransfusion System Revenue Market Share by Country (2021–2032)

Figure 27. Germany Cardiopulmonary Autotransfusion System Revenue Growth Rate (US$ Million), 2021–2032

Figure 28. France Cardiopulmonary Autotransfusion System Revenue Growth Rate (US$ Million), 2021–2032

Figure 29. U.K. Cardiopulmonary Autotransfusion System Revenue Growth Rate (US$ Million), 2021–2032

Figure 30. Italy Cardiopulmonary Autotransfusion System Revenue Growth Rate (US$ Million), 2021–2032

Figure 31. Russia Cardiopulmonary Autotransfusion System Revenue Growth Rate (US$ Million), 2021–2032

Figure 32. Asia Pacific Cardiopulmonary Autotransfusion System Sales Market Share by Region (2021–2032)

Figure 33. Asia Pacific Cardiopulmonary Autotransfusion System Revenue Market Share by Region (2021–2032)

Figure 34. China Cardiopulmonary Autotransfusion System Revenue Growth Rate (US$ Million), 2021–2032

Figure 35. Japan Cardiopulmonary Autotransfusion System Revenue Growth Rate (US$ Million), 2021–2032

Figure 36. South Korea Cardiopulmonary Autotransfusion System Revenue Growth Rate (US$ Million), 2021–2032

Figure 37. India Cardiopulmonary Autotransfusion System Revenue Growth Rate (US$ Million), 2021–2032

Figure 38. Australia Cardiopulmonary Autotransfusion System Revenue Growth Rate (US$ Million), 2021–2032

Figure 39. China Taiwan Cardiopulmonary Autotransfusion System Revenue Growth Rate (US$ Million), 2021–2032

Figure 40. Indonesia Cardiopulmonary Autotransfusion System Revenue Growth Rate (US$ Million), 2021–2032

Figure 41. Thailand Cardiopulmonary Autotransfusion System Revenue Growth Rate (US$ Million), 2021–2032

Figure 42. Malaysia Cardiopulmonary Autotransfusion System Revenue Growth Rate (US$ Million), 2021–2032

Figure 43. Latin America Cardiopulmonary Autotransfusion System Sales Market Share by Country (2021–2032)

Figure 44. Latin America Cardiopulmonary Autotransfusion System Revenue Market Share by Country (2021–2032)

Figure 45. Mexico Cardiopulmonary Autotransfusion System Revenue Growth Rate (US$ Million), 2021–2032

Figure 46. Brazil Cardiopulmonary Autotransfusion System Revenue Growth Rate (US$ Million), 2021–2032

Figure 47. Argentina Cardiopulmonary Autotransfusion System Revenue Growth Rate (US$ Million), 2021–2032

Figure 48. Middle East and Africa Cardiopulmonary Autotransfusion System Sales Market Share by Country (2021–2032)

Figure 49. Middle East and Africa Cardiopulmonary Autotransfusion System Revenue Market Share by Country (2021–2032)

Figure 50. Turkey Cardiopulmonary Autotransfusion System Revenue Growth Rate (US$ Million), 2021–2032

Figure 51. Saudi Arabia Cardiopulmonary Autotransfusion System Revenue Growth Rate (US$ Million), 2021–2032

Figure 52. UAE Cardiopulmonary Autotransfusion System Revenue Growth Rate (US$ Million), 2021–2032

Figure 53. Global Sales Market Share of Cardiopulmonary Autotransfusion System by Type (2021–2032)

Figure 54. Global Revenue Market Share of Cardiopulmonary Autotransfusion System by Type (2021–2032)

Figure 55. Global Cardiopulmonary Autotransfusion System Price (USD/Unit) by Type (2021–2032)

Figure 56. Global Sales Market Share of Cardiopulmonary Autotransfusion System by Application (2021–2032)

Figure 57. Global Revenue Market Share of Cardiopulmonary Autotransfusion System by Application (2021–2032)

Figure 58. Global Cardiopulmonary Autotransfusion System Price (USD/Unit) by Application (2021–2032)

Figure 59. Cardiopulmonary Autotransfusion System Value Chain

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Autotransfusion Devices and Consumables Market Insights Forecast to 2030

Global Cardiopulmonary Autotransfusion Devices Market Research Report 2024

Global Autotransfusion Blood Bags Market Insights Forecast to 2030

Autotransfusion Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Autologous Blood Transfusion System Market Research Report 2025

Auto Transfusion System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Autologous Transfusion Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Autotransfusion Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Autologous Platelet Concentrating System Market Research Report 2024

Global Autologous Blood Recovery System Market Research Report 2025

Blood Recovery Machine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Blood Conservation System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Blood Transfusion Market Research Report 2025

Global Self Collecting Blood Storage Devices Market Research Report 2025

Global Fully Automatic Blood Refrigeration System Market Research Report 2024

Global Fully Automatic Blood Separator Market Research Report 2024

Blood Transfusion Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cardiopulmonary Bypass Machine Market Research Report 2025

Global Fully Automatic Blood Component Separator Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions